MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    The Clinical and Biological effects of a Whole Foods and Plant-Based Dietary Intervention in Parkinson’s Disease

    B. Boon, S. Meles, B. Bloem, T. van Laar, E. Postma (Groningen, Netherlands)

    Objective: The Plants for Parkinson trial aims to investigate whether prolonged adherence to a plant-based and whole foods-derived dietary pattern can alleviate motor- and gastrointestinal…
  • 2026 International Congress

    When Surgical Candidates Become Ineligible: Loss of Deep Brain Stimulation Eligibility in Parkinson’s Disease — A Descriptive Study from a Brazilian Referral Center

    J. Sánchez-León, I. Da-Silva-Gomes, T. Schlickmann, T. Lampert Monte, B. Fraiman, D. Teixeira-Dos-Santos, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To describe the clinical and non-clinical reasons leading to loss of surgical eligibility among patients initially considered candidates for Deep Brain Stimulation (DBS) in…
  • 2026 International Congress

    Impact of Symptom-Specific Odorants on the Diagnostic Accuracy of Brief Olfactory Tests in Parkinson’s Disease

    TC. Fang, YH. Lin, MH. Chang, YJ. Guo (Taichung, Taiwan)

    Objective: To evaluate whether the addition of PD symptom-specific odorants improves diagnostic accuracy in distinguishing patients with PD from healthy controls. Background: Parkinson’s disease (PD)…
  • 2026 International Congress

    About Data Missingness in Wearable Monitoring of Parkinson’s Disease

    E. Roveroni, M. Moretto, A. Giupponi, M. Castellaro, T. Gandolfi, M. Veronese (Padova, Italy)

    Objective: To examine how adherence and data completeness vary throughout the day in wearable monitoring of people with Parkinson’s disease (PwPD), and whether missing data patterns are associated with disease severity. Background: Wearable devices…
  • 2026 International Congress

    Improved “Good On” Time and Reduced Motor Fluctuations After Switching to IPX203: Interim Real-World Results from the First 111 Patients in ELEVATE PD

    R. Hauser, S. Isaacson, S. Betté, A. Richmond, M. Jay, G. Banisadr, S. Fisher, H. Visser (Tampa, USA)

    Objective: Evaluate interim outcomes from the real-world study of IPX203, assessing its impact to extend “Good On” time and reduce “Off” time in PD patients…
  • 2026 International Congress

    LFP-Based Deep Brain Stimulation Programming and Transition to Adaptive Deep Brain Stimulation in a Patient with Parkinson’s Disease: A Case Report from Thailand

    O. Phokaewvarangkul, N. Likhitwitayawuid, K. Sanyawut, N. Rattanapitak, R. Bhidayasiri (Bangkok, Thailand)

    Objective: This case report represents one of the first practical implementations of LFP-guided programming and adaptive DBS in Thailand. Background: Deep brain stimulation (DBS) of…
  • 2026 International Congress

    DBS Evoked Cortical Potentials Can Predict Tremor Suppression

    TA. Dembek, C. Schedlich-Teufer, E. Reise, C. Van-Der-Linden, JN. Petry-Schmelzer, V. Visser-Vandewalle, A. Horn, MT. Barbe (Cologne, Germany)

    Objective: To relate the DBS evoked cortical potential (ECP) P25 to the suppression of tremor. Background: DBS‑ECPs have been investigated in DBS of the subthalamic…
  • 2026 International Congress

    Diagnostic Validity of PD Identification in a Neurologist-Certified National Drug Reimbursement Registry

    V. Räty, T. Kuusimäki, T. Vahlberg, A-M. Tolppanen, V. Kaasinen (Turku, Finland)

    Objective: To evaluate the diagnostic validity of PD identification in a national drug reimbursement registry requiring neurologist-confirmed diagnoses. Background: Administrative healthcare databases are widely used…
  • 2026 International Congress

    Assessing The Role Of Afg3l2 Pathogenic Variants In Parkinson’s Disease

    V. Quintana-Peña, I. Keller Sarmiento, B. Bustos, L. Lange, K. Lohmann, R. Alcalay, M. Marti, N. Okubadejo, S. Lim, T. Foroud, R. Kaiyrzhanov, E. Valente, R. Krüger, H. Morris, B. Jeon, C. Klein, J. Trinh, N. Mencacci (Chicago, USA)

    Objective: The aim of this study is to investigate the potential link between AFG3L2 rare pathogenic/likely pathogenic variants with Parkinson’s disease (PD). Background: AFG3L2 is…
  • 2026 International Congress

    Deciphering the NLRP3-Driven Olfactory–Brain Axis in Parkinson’s disease: Neuroprotective Role of Betulin

    A. Kumar, V. Malhotra (Ahamdabad, India)

    Objective: The present study aimed to elucidate the molecular mechanism underlying bidirectional olfactory–brain dysfunction mediated through NLRP3 inflammasome activation in cellular models of PD and…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley